NCT05950750 Turkey Thrombotic Thrombocytopenic Purpura Disease Registry: National Multicenter Study
| NCT ID | NCT05950750 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Turkish Hematology Association |
| Condition | TTP - Thrombotic Thrombocytopenic Purpura |
| Study Type | OBSERVATIONAL |
| Enrollment | 960 participants |
| Start Date | 2022-12-21 |
| Primary Completion | 2023-12-21 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 960 participants in total. It began in 2022-12-21 with a primary completion date of 2023-12-21.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
21 hematology centers in Turkey will participate in this noninterventional observational study. The recruitment target is 960 cases. Patients will be followed-up at least 1 year or to the end of the study according to the physicians' discretion, or withdrawal of consent. Recruitment period will be 36 months. Data will be collected via electronic case report form. Since the study cohort does not include only newly diagnosed patients, all aTTP patients will be included to the study, previous treatments and diagnosis information data could also be collected from hospital records. Patients recruitment duration: 3 years (36 months) Patients follow-up duration: 1 year (12 months)
Eligibility Criteria
Inclusion Criteria: * Diagnosed as aTTP after 01.01.2015 * Patients with ADAMS13\<10% * Thrombocytopenia (\<100.000) * Coombs (-) * Microangiopathic hemolytic amenia * 18 years and older Exclusion Criteria: \- Patient who does not sign informed consent form
Contact & Investigator
ilker kurkcu
STUDY DIRECTOR
Sentez-CRO
Frequently Asked Questions
Who can join the NCT05950750 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying TTP - Thrombotic Thrombocytopenic Purpura. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05950750 currently recruiting?
Yes, NCT05950750 is actively recruiting participants. Contact the research team at ilker.kurkcu@sentez-cro.com for enrollment information.
Where is the NCT05950750 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT05950750 clinical trial?
NCT05950750 is sponsored by Turkish Hematology Association. The principal investigator is ilker kurkcu at Sentez-CRO. The trial plans to enroll 960 participants.